INS and sarcopenia: The common mechanisms of T2DM and sarcopenia mainly include insulin resistance, mitochondrial dysfunction, systemic chronic inflammation, fat accumulation, etc. In T2DM patients, hyperglycemia toxicity and increased fatty acid concentration will lead to insulin secretion and insulin resistance, which in turn will promote the rise of blood sugar and fatty acids.